Loading...

News

Baltics leading pharmaceutical company G
PRNEWSWIRE February 17,2025 0

Dr Massimo Cristofanilli, MD Joins Datar
PRNEWSWIRE February 11,2025 0

VJ Biosciences Debuts at 5th Annual Summ
PRNEWSWIRE February 03,2025 0

X4 Pharmaceuticals Announces EMA Validat
PRNEWSWIRE January 24,2025 0

TraceLink Named to the 2025 RXinsider Ph
PRNEWSWIRE January 22,2025 0

JelloX Aims to Improve Patient-Centered
PRNEWSWIRE January 22,2025 0

Makers of ORSL® expand their Rehydratio
PRNEWSWIRE January 22,2025 0

SIRPAD - WORLD'S LARGEST RCT INVESTIGATI
PRNEWSWIRE January 20,2025 0

BioCina and NovaCina Merger Bolsters Glo
PRNEWSWIRE January 13,2025 0

Menarini Group and Insilico Medicine Ent
PRNEWSWIRE January 10,2025 0

Keycentrix and UST Announce Strategic Pa
PRNEWSWIRE January 09,2025 0

Clarivate Identifies Eleven Potential Bl
PRNEWSWIRE January 08,2025 0

Concept Medical Announces Successful SIR
PRNEWSWIRE January 07,2025 0

Macsen Labs Group Commences Construction
PRNEWSWIRE January 06,2025 0

Veeda Group Rebrands as 'Veeda Lifescien
PRNEWSWIRE January 02,2025 0

Menarini Group announces Positive Toplin
PRNEWSWIRE December 16,2024 0

Bushu Pharma Applauded by Frost & Su
PRNEWSWIRE December 15,2024 0

Axtria Leads Frost & Sullivan's Firs
PRNEWSWIRE December 12,2024 0

Menarini Group and MEDSIR Present the Ph
PRNEWSWIRE December 12,2024 0

TraceLink Successfully Completes Industr
PRNEWSWIRE December 09,2024 0

EpiVax Drives Immunogenicity Innovation
PRNEWSWIRE December 07,2024 0

Recent News

Baltics leading pharmaceutical company Grindeks
Dr Massimo Cristofanilli, MD Joins
VJ Biosciences Debuts at 5th
X4 Pharmaceuticals Announces EMA Validation
TraceLink Named to the 2025
JelloX Aims to Improve Patient-Centered
Makers of ORSL® expand their
SIRPAD - WORLD\'S LARGEST RCT
BioCina and NovaCina Merger Bolsters
Menarini Group and Insilico Medicine
Keycentrix and UST Announce Strategic
Clarivate Identifies Eleven Potential Blockbuster
Concept Medical Announces Successful SIRONA
Macsen Labs Group Commences Construction
Veeda Group Rebrands as \'Veeda
Menarini Group announces Positive Topline
Bushu Pharma Applauded by Frost
Axtria Leads Frost & Sullivan\'s
Menarini Group and MEDSIR Present
TraceLink Successfully Completes Industry-Leading Audits:
EpiVax Drives Immunogenicity Innovation in
Visitor Count 12250